日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Carbon-Ion radiotherapy alone for inoperable locally advanced Non-Small cell lung cancer: A Japanese National registry study (J-CROS-LUNG)

碳离子放射疗法单独用于无法手术的局部晚期非小细胞肺癌：日本国家登记研究（J-CROS-LUNG）

期刊:Japanese Journal of Radiology
影响因子:4.1
doi:10.1007/s11604-025-01925-z
Aoki, Shuri; Suefuji, Hiroaki; Nakajima, Mio; Kubo, Nobuteru; Suzuki, Osamu; Satouchi, Miyako; Shimizu, Kimihiro; Fujisawa, Takehiko; Umehara, Kensuke; Ishikawa, Hitoshi; Shioyama, Yoshiyuki
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

RELAY+: Final Overall Survival With Ramucirumab Plus Gefitinib in Patients With Untreated EGFR-Mutated Metastatic NSCLC

RELAY+：雷莫芦单抗联合吉非替尼治疗未经治疗的EGFR突变转移性非小细胞肺癌患者的最终总生存期

期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2025.100912
Nishio, Makoto; Seto, Takashi; Reck, Martin; Garon, Edward B; Nishio, Kazuto; Kasahara, Kazuo; Nishino, Kazumi; Satouchi, Miyako; Yoh, Kiyotaka; Hayashi, Hidetoshi; Sakai, Kazuko; Enatsu, Sotaro; Matsui, Tomoko; Varughese, Sunoj Chacko; Carlsen, Michelle; Visseren-Grul, Carla; Nakagawa, Kazuhiko
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
发表日期：2025
文献求助 收藏

Final Survival Outcomes With Ramucirumab Plus Erlotinib Versus Placebo Plus Erlotinib in Patients With Untreated EGFR-Mutated Metastatic NSCLC: RELAY Japanese Subset

在未经治疗的EGFR突变转移性非小细胞肺癌患者中，雷莫芦单抗联合厄洛替尼与安慰剂联合厄洛替尼的最终生存结果：RELAY日本亚组

期刊:JTO Clinical and Research Reports
影响因子:3.5
doi:10.1016/j.jtocrr.2025.100819
Nishio, Makoto; Seto, Takashi; Reck, Martin; Garon, Edward B; Nishio, Kazuto; Kasahara, Kazuo; Nishino, Kazumi; Satouchi, Miyako; Yoh, Kiyotaka; Hayashi, Hidetoshi; Sakai, Kazuko; Enatsu, Sotaro; Frimodt-Møller, Bente; Matsui, Tomoko; Varughese, Sunoj Chacko; Carlsen, Michelle; Visseren-Grul, Carla; Nakagawa, Kazuhiko
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
发表日期：2025
文献求助 收藏

RELAY: safety and efficacy of ramucirumab plus erlotinib in elderly Japanese patients with metastatic EGFR-mutated NSCLC

RELAY：雷莫芦单抗联合厄洛替尼治疗老年EGFR突变型非小细胞肺癌患者的安全性和有效性

期刊:Future Oncology
影响因子:2.6
doi:10.1080/14796694.2025.2560225
Nishino, Kazumi; Seto, Takashi; Nishio, Makoto; Nishio, Kazuto; Kasahara, Kazuo; Satouchi, Miyako; Yoh, Kiyotaka; Hayashi, Hidetoshi; Enatsu, Sotaro; Matsui, Tomoko; Varughese, Sunoj Chacko; Visseren-Grul, Carla; Nakagawa, Kazuhiko
肺癌
肿瘤
肿瘤免疫
EGF
EGFR
细胞生物学
发表日期：2025
文献求助 收藏

Phase II Study of the Liposomal Formulation of Eribulin (E7389-LF) in Combination with Nivolumab: Results from the Small Cell Lung Cancer Cohort

脂质体艾立布林（E7389-LF）联合纳武利尤单抗治疗小细胞肺癌队列的II期研究结果

期刊:Cancer Research Communications
影响因子:3.3
doi:10.1158/2767-9764.CRC-23-0313
Nishio, Makoto; Murakami, Shuji; Kawakami, Hisato; Okishio, Kyoichi; Tamiya, Motohiro; Kobayashi, Haruki; Fujimoto, Daichi; Sugawara, Shunichi; Kozuki, Toshiyuki; Oya, Yuko; Izumi, Hiroki; Shiroyama, Takayuki; Satouchi, Miyako; Yamamoto, Noboru; Kaname, Shota; Matsuoka, Daiko; Otake, Yohei; Takase, Takao; Semba, Taro; Azuma, Koichi
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

KEYNOTE-434 part B: A phase 1 study evaluating the combination of epacadostat, pembrolizumab, and chemotherapy in Japanese patients with previously untreated advanced non-small-cell lung cancer

KEYNOTE-434 B 部分：一项评估 epacadostat、pembrolizumab 和化疗联合治疗既往未接受治疗的日本晚期非小细胞肺癌患者的 1 期研究

期刊:Investigational New Drugs
影响因子:2.7
doi:10.1007/s10637-024-01422-6
Yamamoto, Noboru; Satouchi, Miyako; Doi, Toshihiko; Fujiwara, Yutaka; Yanagitani, Noriko; Kawa, Yoshitaka; Yoh, Kiyotaka; Leopold, Lance; Munteanu, Mihaela; Sawada, Takashi; Han, Shirong; Noguchi, Kazuo; Nishio, Makoto
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Phase 1 study of pembrolizumab plus chemotherapy in Japanese patients with extensive-stage small-cell lung cancer

一项针对日本广泛期小细胞肺癌患者的帕博利珠单抗联合化疗的I期研究

期刊:Investigational New Drugs
影响因子:2.7
doi:10.1007/s10637-023-01411-1
Nogami, Naoyuki; Tokito, Takaaki; Zenke, Yoshitaka; Satouchi, Miyako; Seto, Takashi; Saka, Hideo; Ohtani, Junko; Han, Shirong; Noguchi, Kazuo; Nishio, Makoto
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏

Durvalumab Plus Concurrent Radiotherapy for Treatment of Locally Advanced Non-Small Cell Lung Cancer: The DOLPHIN Phase 2 Nonrandomized Controlled Trial

Durvalumab联合同步放疗治疗局部晚期非小细胞肺癌：DOLPHIN II期非随机对照试验

期刊:Jama Oncology
影响因子:20.1
doi:10.1001/jamaoncol.2023.3309
Tachihara, Motoko; Tsujino, Kayoko; Ishihara, Takeaki; Hayashi, Hidetoshi; Sato, Yuki; Kurata, Takayasu; Sugawara, Shunichi; Shiraishi, Yoshimasa; Teraoka, Shunsuke; Azuma, Koichi; Daga, Haruko; Yamaguchi, Masafumi; Kodaira, Takeshi; Satouchi, Miyako; Shimokawa, Mototsugu; Yamamoto, Nobuyuki; Nakagawa, Kazuhiko
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Pembrolizumab plus chemotherapy in Japanese patients with metastatic squamous non-small-cell lung cancer in KEYNOTE-407

KEYNOTE-407 研究评估了帕博利珠单抗联合化疗治疗日本转移性鳞状非小细胞肺癌患者的疗效

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.15816
Sugawara, Shunichi; Tanaka, Kentaro; Imamura, Fumio; Yamamoto, Nobuyuki; Nishio, Makoto; Okishio, Kyoichi; Hirashima, Tomonori; Tanaka, Hiroshi; Fukuhara, Tatsuro; Nakahara, Yasuharu; Kurata, Takayasu; Katakami, Nobuyuki; Okada, Morihito; Horinouchi, Hidehito; Udagawa, Hibiki; Kasahara, Kazuo; Satouchi, Miyako; Saka, Hideo; Tokito, Takaaki; Hosomi, Yukio; Aoe, Keisuke; Kishi, Kazuma; Ohashi, Kadoaki; Yokoyama, Takuma; Adachi, Noriaki; Noguchi, Kazuo; Schwarzenberger, Paul; Kato, Terufumi
肺癌
细胞生物学
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

Drug-induced interstitial lung disease after chemoimmunotherapy for extensive-stage small cell lung cancer

广泛期小细胞肺癌化疗免疫治疗后药物引起的间质性肺病

期刊:Heliyon
影响因子:3.6
doi:10.1016/j.heliyon.2023.e20463
Fukuda, Kiyoko; Katsurada, Naoko; Kawa, Yoshitaka; Satouchi, Miyako; Kaneshiro, Kazumi; Matsumoto, Masataka; Takamiya, Rei; Hatakeyama, Yukihisa; Dokuni, Ryota; Matsumura, Kanoko; Katsurada, Masahiro; Nakata, Kyosuke; Yoshimura, Sho; Tachihara, Motoko
肺癌
肿瘤
特发性肺纤维化
肿瘤免疫
细胞生物学
免疫/内分泌
发表日期：2023
文献求助 收藏